 | • レポートコード：GIR-22F19672 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Transdermal Skin Patch Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の経皮皮膚パッチの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 経皮皮膚パッチ市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・フェンタニル経皮皮膚貼付剤、ニコチン経皮皮膚貼付剤、クロニジン経皮皮膚貼付剤、ブプレノルフィン経皮皮膚貼付剤 アプリケーション別セグメントは次のように区分されます。 ・激しい痛みの緩和、禁煙、過活動膀胱治療、その他 世界の経皮皮膚パッチ市場の主要な市場プレーヤーは以下のとおりです。 ・Hisamitsu Pharmaceutical、Novartis、Johnson & Johnson、Teikoku Pharma、Mylan、Actavis、Mundipharma、Henan Lingrui Pharmaceutical、Changzhou Siyao、Rfl Pharmaceutical、Luye Pharma Group Ltd.、Purdue Pharma L.P.、Teva Pharmaceutical Industries Ltd. 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、経皮皮膚パッチ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な経皮皮膚パッチメーカーの企業概要、2019年～2022年までの経皮皮膚パッチの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な経皮皮膚パッチメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別経皮皮膚パッチの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの経皮皮膚パッチのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経皮皮膚パッチ市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および経皮皮膚パッチの産業チェーンを掲載しています。 ・第13、14、15章では、経皮皮膚パッチの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 経皮皮膚パッチの概要 - タイプ別分析（2017年vs2021年vs2028年）：フェンタニル経皮皮膚貼付剤、ニコチン経皮皮膚貼付剤、クロニジン経皮皮膚貼付剤、ブプレノルフィン経皮皮膚貼付剤 - アプリケーション別分析（2017年vs2021年vs2028年）：激しい痛みの緩和、禁煙、過活動膀胱治療、その他 - 世界の経皮皮膚パッチ市場規模・予測 - 世界の経皮皮膚パッチ生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Hisamitsu Pharmaceutical、Novartis、Johnson & Johnson、Teikoku Pharma、Mylan、Actavis、Mundipharma、Henan Lingrui Pharmaceutical、Changzhou Siyao、Rfl Pharmaceutical、Luye Pharma Group Ltd.、Purdue Pharma L.P.、Teva Pharmaceutical Industries Ltd. ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：フェンタニル経皮皮膚貼付剤、ニコチン経皮皮膚貼付剤、クロニジン経皮皮膚貼付剤、ブプレノルフィン経皮皮膚貼付剤 ・アプリケーション別分析2017年-2028年：激しい痛みの緩和、禁煙、過活動膀胱治療、その他 ・経皮皮膚パッチの北米市場分析 - 経皮皮膚パッチの北米市場：タイプ別市場規模2017年-2028年 - 経皮皮膚パッチの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・経皮皮膚パッチのヨーロッパ市場分析 - ：経皮皮膚パッチのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：経皮皮膚パッチのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・経皮皮膚パッチのアジア太平洋市場分析 - 経皮皮膚パッチのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 経皮皮膚パッチのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・経皮皮膚パッチの南米市場分析 - 経皮皮膚パッチの南米市場：タイプ別市場規模2017年-2028年 - 経皮皮膚パッチの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・経皮皮膚パッチの中東・アフリカ市場分析 - 経皮皮膚パッチの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 経皮皮膚パッチの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Transdermal Skin Patch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transdermal Skin Patch market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Relieve Severe Pain accounting for % of the Transdermal Skin Patch global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fentanyl Transdermal Skin Patch segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transdermal Skin Patch market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Market segment by Application can be divided into
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
The key market players for global Transdermal Skin Patch market are listed below:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Skin Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Skin Patch, with price, sales, revenue and global market share of Transdermal Skin Patch from 2019 to 2022.
Chapter 3, the Transdermal Skin Patch competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Skin Patch breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal Skin Patch market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Skin Patch.
Chapter 13, 14, and 15, to describe Transdermal Skin Patch sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Transdermal Skin Patch Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Skin Patch Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Fentanyl Transdermal Skin Patch
1.2.3 Nicotine Transdermal Skin Patch
1.2.4 Clonidine Transdermal Skin Patch
1.2.5 Buprenorphine Transdermal Skin Patch
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Skin Patch Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat an Overactive Bladder
1.3.5 Others
1.4 Global Transdermal Skin Patch Market Size & Forecast
1.4.1 Global Transdermal Skin Patch Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Transdermal Skin Patch Sales in Volume (2017-2028)
1.4.3 Global Transdermal Skin Patch Price (2017-2028)
1.5 Global Transdermal Skin Patch Production Capacity Analysis
1.5.1 Global Transdermal Skin Patch Total Production Capacity (2017-2028)
1.5.2 Global Transdermal Skin Patch Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Skin Patch Market Drivers
1.6.2 Transdermal Skin Patch Market Restraints
1.6.3 Transdermal Skin Patch Trends Analysis
2 Manufacturers Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Transdermal Skin Patch Product and Services
2.2.4 Novartis Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Transdermal Skin Patch Product and Services
2.3.4 Johnson & Johnson Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Teikoku Pharma
2.4.1 Teikoku Pharma Details
2.4.2 Teikoku Pharma Major Business
2.4.3 Teikoku Pharma Transdermal Skin Patch Product and Services
2.4.4 Teikoku Pharma Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Skin Patch Product and Services
2.5.4 Mylan Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Actavis
2.6.1 Actavis Details
2.6.2 Actavis Major Business
2.6.3 Actavis Transdermal Skin Patch Product and Services
2.6.4 Actavis Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mundipharma
2.7.1 Mundipharma Details
2.7.2 Mundipharma Major Business
2.7.3 Mundipharma Transdermal Skin Patch Product and Services
2.7.4 Mundipharma Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Henan Lingrui Pharmaceutical
2.8.1 Henan Lingrui Pharmaceutical Details
2.8.2 Henan Lingrui Pharmaceutical Major Business
2.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product and Services
2.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Changzhou Siyao
2.9.1 Changzhou Siyao Details
2.9.2 Changzhou Siyao Major Business
2.9.3 Changzhou Siyao Transdermal Skin Patch Product and Services
2.9.4 Changzhou Siyao Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Rfl Pharmaceutical
2.10.1 Rfl Pharmaceutical Details
2.10.2 Rfl Pharmaceutical Major Business
2.10.3 Rfl Pharmaceutical Transdermal Skin Patch Product and Services
2.10.4 Rfl Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Luye Pharma Group Ltd.
2.11.1 Luye Pharma Group Ltd. Details
2.11.2 Luye Pharma Group Ltd. Major Business
2.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Product and Services
2.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Purdue Pharma L.P.
2.12.1 Purdue Pharma L.P. Details
2.12.2 Purdue Pharma L.P. Major Business
2.12.3 Purdue Pharma L.P. Transdermal Skin Patch Product and Services
2.12.4 Purdue Pharma L.P. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Teva Pharmaceutical Industries Ltd.
2.13.1 Teva Pharmaceutical Industries Ltd. Details
2.13.2 Teva Pharmaceutical Industries Ltd. Major Business
2.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product and Services
2.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Transdermal Skin Patch Breakdown Data by Manufacturer
3.1 Global Transdermal Skin Patch Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Transdermal Skin Patch Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Transdermal Skin Patch
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Skin Patch Manufacturer Market Share in 2021
3.4.2 Top 6 Transdermal Skin Patch Manufacturer Market Share in 2021
3.5 Global Transdermal Skin Patch Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Transdermal Skin Patch Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Skin Patch Market Size by Region
4.1.1 Global Transdermal Skin Patch Sales in Volume by Region (2017-2028)
4.1.2 Global Transdermal Skin Patch Revenue by Region (2017-2028)
4.2 North America Transdermal Skin Patch Revenue (2017-2028)
4.3 Europe Transdermal Skin Patch Revenue (2017-2028)
4.4 Asia-Pacific Transdermal Skin Patch Revenue (2017-2028)
4.5 South America Transdermal Skin Patch Revenue (2017-2028)
4.6 Middle East and Africa Transdermal Skin Patch Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Transdermal Skin Patch Sales in Volume by Type (2017-2028)
5.2 Global Transdermal Skin Patch Revenue by Type (2017-2028)
5.3 Global Transdermal Skin Patch Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Transdermal Skin Patch Sales in Volume by Application (2017-2028)
6.2 Global Transdermal Skin Patch Revenue by Application (2017-2028)
6.3 Global Transdermal Skin Patch Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Skin Patch Sales by Type (2017-2028)
7.2 North America Transdermal Skin Patch Sales by Application (2017-2028)
7.3 North America Transdermal Skin Patch Market Size by Country
7.3.1 North America Transdermal Skin Patch Sales in Volume by Country (2017-2028)
7.3.2 North America Transdermal Skin Patch Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Skin Patch Sales by Type (2017-2028)
8.2 Europe Transdermal Skin Patch Sales by Application (2017-2028)
8.3 Europe Transdermal Skin Patch Market Size by Country
8.3.1 Europe Transdermal Skin Patch Sales in Volume by Country (2017-2028)
8.3.2 Europe Transdermal Skin Patch Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Transdermal Skin Patch Sales by Type (2017-2028)
9.2 Asia-Pacific Transdermal Skin Patch Sales by Application (2017-2028)
9.3 Asia-Pacific Transdermal Skin Patch Market Size by Region
9.3.1 Asia-Pacific Transdermal Skin Patch Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Transdermal Skin Patch Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Transdermal Skin Patch Sales by Type (2017-2028)
10.2 South America Transdermal Skin Patch Sales by Application (2017-2028)
10.3 South America Transdermal Skin Patch Market Size by Country
10.3.1 South America Transdermal Skin Patch Sales in Volume by Country (2017-2028)
10.3.2 South America Transdermal Skin Patch Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Skin Patch Sales by Type (2017-2028)
11.2 Middle East & Africa Transdermal Skin Patch Sales by Application (2017-2028)
11.3 Middle East & Africa Transdermal Skin Patch Market Size by Country
11.3.1 Middle East & Africa Transdermal Skin Patch Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Transdermal Skin Patch Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Transdermal Skin Patch and Key Manufacturers
12.2 Manufacturing Costs Percentage of Transdermal Skin Patch
12.3 Transdermal Skin Patch Production Process
12.4 Transdermal Skin Patch Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Transdermal Skin Patch Typical Distributors
13.3 Transdermal Skin Patch Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer